The Adverse Outcome Pathway for Oxidative Stress-Mediated EGFR Activation Leading to Decreased Lung Function
Applied In Vitro Toxicology · 2017-03 · 3 (1) · 99-109
DOI: 10.1089/aivt.2016.0032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied In Vitro Toxicology, 2017-03. Verfasst von Karsta Luettich und 6 weiteren Autor:innen. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 134 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Luettich, K., Talikka, M., Lowe, F. J., Haswell, L. E., Park, J., Gaca, M. D., & Hoeng, J. (2017). The Adverse Outcome Pathway for Oxidative Stress-Mediated EGFR Activation Leading to Decreased Lung Function. Applied In Vitro Toxicology, 3(1), 99-109. https://doi.org/10.1089/aivt.2016.0032
Vancouver
Luettich K, Talikka M, Lowe FJ, Haswell LE, Park J, Gaca MD, et al. The Adverse Outcome Pathway for Oxidative Stress-Mediated EGFR Activation Leading to Decreased Lung Function. Applied In Vitro Toxicology. 2017;3(1):99-109. doi:10.1089/aivt.2016.0032
BibTeX
@article{Luettich2017,
author = {Luettich, Karsta and Talikka, Marja and Lowe, Frazer J. and Haswell, Linsey E. and Park, Jennifer and Gaca, Marianna D. and Hoeng, Julia},
title = {The Adverse Outcome Pathway for Oxidative Stress-Mediated EGFR Activation Leading to Decreased Lung Function},
journal = {Applied In Vitro Toxicology},
year = {2017},
volume = {3},
number = {1},
pages = {99--109},
doi = {10.1089/aivt.2016.0032}
}
EUVIMED